Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02575872 · ClinicalTrials.gov registry record · NA

Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT02575872: Completed NA study, sponsored by Albert Einstein College of Medicine.

NCT02575872 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02575872, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This randomized clinical trial studies a physical activity behavioral intervention in obese endometrial cancer survivors. Learning about physical activity behavior while participating in a fitness class may help increase physical activity and improve the quality of life of obese endometrial cancer survivors.

Primary Outcome

Data will be analyzed using Pearson Chi-square test.

Interventions

  • BEHAVIORAL Exercise Intervention

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-10
Est. Completion 2018-06
Phase NA
Albert Einstein College of Medicine

175 total trials

What the finished NCT02575872 record still lists

NCT02575872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise Intervention is the first listed.

NCT02575872 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02575872 about?

NCT02575872 is a clinical study titled "Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors". This randomized clinical trial studies a physical activity behavioral intervention in obese endometrial cancer survivors. Learning about physical activity behavior while participating in a fitness class may help increase physical activity and improve the quality of life of obese endometrial cancer s...

What is the current status of trial NCT02575872?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-10. Estimated completion is 2018-06.

What interventions are being tested in trial NCT02575872?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02575872?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02575872's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02575872, the US trial registry maintained by the National Library of Medicine. NCT02575872 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.